Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program (Q44684144)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program |
scientific article |
Statements
1 reference
Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program (English)
1 reference
Mihai Gheorghiade
1 reference
Liliana Grinfeld
1 reference
Faiez Zannad
1 reference
Karl Swedberg
1 reference
James E Udelson
1 reference
Christopher Zimmer
1 reference
John E A Blair
1 reference
Marvin A Konstam
1 reference
Thomas Cook
1 reference
Brian Traver
1 reference
John C Burnett
1 reference
Holly Krasa
1 reference
Aldo P Maggioni
1 reference
Cesare Orlandi
1 reference
EVEREST Investigators
1 reference
1 November 2008
1 reference
1 reference
52
1 reference
20
1 reference
1640-1648
1 reference
Identifiers
1 reference
1 reference